Advances in Peptide Therapeutics (Technical Insights)

 


Peptides have been prevalent as biopharmaceutical entities since the past twenty years but have come into focus only in the last five to six years due to improvements in manufacturing processes and delivery technologies. This research service aims to provide a strategic picture of therapeutic peptides from a research and development portfolio perspective and delineate the most critical criteria to be considered during evaluation of R&D portfolio projects. Using the current research scenario, market potential data and technical features of peptide drugs as tools, it provides a decision-making base for stakeholders at all stages in this industrial sector from small biotechnology companies to big pharmaceutical organizations.

Regular Price: USD 4,950

Special Price USD 3,465

30% OFF

* Required Fields

Regular Price: USD 4,950

Special Price USD 3,465

PAY BY INVOICE

Be the first to review this product

Table of Contents

Advances in Peptide Therapeutics (Technical Insights), Peptide TherapeuticsAdvances in Peptide TherapeuticsAdvances in Peptide Therapeutics




Related Research

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.